General Pharmacology — MCQs

A three-year-old child is brought to the emergency department having just ingested a large overdose of an antihistaminic drug. This drug is a weak base capable of entering most tissues, including the brain. On physical examination, the heart rate is 100/minute, blood pressure is 110/60 mm Hg, and the respiratory rate is 20/minute. In this case of poisoning, which of the following is true regarding the management?

Q450Easy

Epinephrine added to a solution of lignocaine for a peripheral nerve block will:

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 441: Teratogenicity results when drugs are given during which period of gestation?

A. First trimester (Correct Answer)
B. Second trimester
C. Third trimester
D. Soon after birth

Explanation: **Explanation:** The correct answer is **A. First trimester**. **1. Why the First Trimester is Correct:** The first trimester (specifically between the **3rd and 8th weeks** of gestation) is the period of **organogenesis**. During this phase, the basic structures of all major organ systems are being formed. This is the period of maximum vulnerability; exposure to teratogens during this window leads to structural malformations (gross anatomical defects). Exposure before the 3rd week usually results in an "all-or-none" phenomenon (either death of the embryo or complete recovery), while exposure after the 8th week primarily affects functional maturation rather than structural integrity. **2. Why Other Options are Incorrect:** * **Second and Third Trimesters:** By this stage, organogenesis is largely complete. Drug exposure during these periods typically leads to **fetotoxicity** (growth retardation, functional impairment, or specific organ toxicity) rather than structural teratogenicity. For example, ACE inhibitors in late pregnancy cause renal dysfunction, not limb defects. * **Soon after birth:** This is the neonatal period. While drugs can cause adverse effects in neonates (e.g., Gray Baby Syndrome with Chloramphenicol), these are classified as pediatric adverse drug reactions, not teratogenicity, as the organs are already fully formed. **3. NEET-PG High-Yield Pearls:** * **Thalidomide:** Causes Phocomelia (seal-like limbs). * **Phenytoin:** Fetal Hydantoin Syndrome (cleft lip/palate, digital hypoplasia). * **Warfarin:** Fetal Warfarin Syndrome (stippled epiphyses, nasal hypoplasia). * **Valproate:** Highest risk for Neural Tube Defects (NTDs). * **Isotretinoin:** Extremely high teratogenic potential (craniofacial, cardiac, and CNS defects); requires strict contraception. * **FDA Categories:** Note that the old A, B, C, D, X categories are being replaced by the Pregnancy and Lactation Labeling Rule (PLLR), but "Category X" (proven risk, contraindicated) remains a common exam term.

Question 442: Pharmacovigilance means:

A. Monitoring of drug safety (Correct Answer)
B. Monitoring of unethical trade of drugs
C. Monitoring pharmaceutical students
D. Monitoring drug efficacy

Explanation: **Explanation:** **Pharmacovigilance (PV)** is defined by the WHO as the science and activities relating to the **detection, assessment, understanding, and prevention of adverse effects** or any other drug-related problems. 1. **Why Option A is Correct:** The primary goal of pharmacovigilance is to ensure **patient safety**. While clinical trials (Phases I-III) provide data on a limited population, rare or long-term adverse drug reactions (ADRs) often emerge only after a drug is marketed to the general public (Phase IV/Post-marketing surveillance). Monitoring drug safety allows for the identification of new safety signals and the implementation of regulatory actions, such as adding "Black Box Warnings" or withdrawing a drug from the market. 2. **Why Other Options are Incorrect:** * **Option B:** Monitoring unethical trade (like smuggling or black marketing) falls under **Drug Regulatory Affairs** and law enforcement (e.g., Narcotics Control Bureau), not pharmacovigilance. * **Option C:** Monitoring students is an academic/administrative function and has no relation to drug safety. * **Option D:** While efficacy is studied in clinical trials, pharmacovigilance specifically focuses on the **risk-benefit ratio**, with a heavy emphasis on the "risk" (safety) aspect. **High-Yield Clinical Pearls for NEET-PG:** * **Phase IV Clinical Trial:** This is the phase most closely associated with pharmacovigilance. * **Pharmacovigilance Programme of India (PvPI):** Launched in 2010; the National Coordinating Centre is the **Indian Pharmacopoeia Commission (IPC)**, Ghaziabad. * **Uppsala Monitoring Centre (UMC):** Located in Sweden, it is the WHO collaborating centre for international drug monitoring. * **Yellow Card Scheme:** A famous spontaneous reporting system for ADRs (originally from the UK).

Question 443: Which cell membrane receptors activate an ion channel upon binding with agonists?

A. Nicotinic cholinergic receptors (Correct Answer)
B. Muscarinic cholinergic receptors
C. Opioid receptors
D. All of the above

Explanation: **Explanation:** The question tests the classification of cell membrane receptors based on their signaling mechanisms. Receptors are broadly divided into four types: Ionotropic, Metabotropic (GPCRs), Enzymatic, and Nuclear receptors. **1. Why Nicotinic Cholinergic Receptors (nAChR) are correct:** Nicotinic receptors are classic examples of **Ionotropic receptors** (Ligand-gated ion channels). Upon binding with an agonist (like Acetylcholine), the receptor undergoes a conformational change that directly opens a central pore, allowing the influx of cations ($Na^+$ and $Ca^{2+}$). This results in rapid depolarization. Because the receptor and the channel are part of the same protein complex, the response is instantaneous (milliseconds). **2. Why the other options are incorrect:** * **Muscarinic Cholinergic Receptors:** These are **G-Protein Coupled Receptors (GPCRs)**. They do not have an intrinsic ion channel; instead, they act through second messengers (like $IP_3/DAG$) or by indirectly opening $K^+$ channels via G-proteins. * **Opioid Receptors ($\mu, \delta, \kappa$):** These are also **GPCRs** (specifically $G_i/G_o$ coupled). They inhibit adenylyl cyclase and indirectly influence ion channels (closing $Ca^{2+}$ or opening $K^+$ channels), but they are not ion channels themselves. **High-Yield Clinical Pearls for NEET-PG:** * **Speed of Response:** Ionotropic (msec) > GPCR (seconds) > Enzymatic (minutes/hours) > Nuclear (hours/days). * **Other Ionotropic Receptors:** $GABA_A$ (Chloride channel), Glycine, 5-$HT_3$ (the only ionotropic Serotonin receptor), and NMDA/AMPA Glutamate receptors. * **Location:** Nicotinic receptors are found at the Neuromuscular Junction ($N_m$) and Autonomic Ganglia ($N_n$). * **Key Distinction:** Remember that **Muscarinic = Metabotropic**, while **Nicotinic = Ionotropic**.

Question 444: Which of the following pairs represent physiological antagonists?

A. Adrenaline and Isoprenaline
B. Glucagon and Insulin (Correct Answer)
C. Isoprenaline and Propranolol
D. All of the above

Explanation: **Explanation:** **Physiological antagonism** (also known as functional antagonism) occurs when two drugs act on **different receptors** and through **different mechanisms**, but produce **opposite effects** on the same physiological system [1]. **1. Why Glucagon and Insulin is correct:** Glucagon and Insulin act on distinct receptors (Glucagon receptors vs. Insulin tyrosine kinase receptors). However, they exert opposing effects on blood glucose levels: Insulin causes hypoglycemia, while Glucagon causes hyperglycemia [2]. Because they cancel each other's functional effects via different pathways, they are classic physiological antagonists [1]. **2. Why the other options are incorrect:** * **Adrenaline and Isoprenaline (Option A):** Both are adrenergic agonists. They act on similar receptors ($\beta$-receptors) to produce synergistic (additive) effects, not antagonistic ones. * **Isoprenaline and Propranolol (Option C):** This is an example of **Pharmacological (Receptor) Antagonism**. Propranolol is a $eta$-blocker that competes with Isoprenaline for the same $eta$-receptor site [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Example:** The most frequently asked example of physiological antagonism is **Adrenaline and Histamine** on bronchial smooth muscle (Adrenaline causes bronchodilation via $eta_2$ receptors; Histamine causes bronchoconstriction via $H_1$ receptors). * **Chemical Antagonism:** Occurs when two drugs react chemically to form an inactive product (e.g., Chelating agents like EDTA for lead poisoning, or Protamine sulfate for Heparin overdose). * **Pharmacokinetic Antagonism:** One drug reduces the concentration of another by interfering with its absorption, metabolism (e.g., Enzyme inducers like Rifampicin), or excretion.

Question 445: All of the following agents act by intracellular receptors EXCEPT:

A. Thyroid hormones
B. Vitamin D
C. Insulin (Correct Answer)
D. Steroids

Explanation: The mechanism of action of a drug depends on its lipid solubility and the location of its target receptor. Receptors are broadly classified into **Cell Surface Receptors** (for water-soluble ligands) and **Intracellular Receptors** (for lipid-soluble ligands) [1]. **Why Insulin is the Correct Answer:** Insulin is a large peptide hormone that is water-soluble and cannot cross the lipid bilayer of the cell membrane. Therefore, it acts via a **Cell Surface Receptor**, specifically a **Receptor Tyrosine Kinase (Enzyme-linked receptor)** [2]. Binding of insulin to the alpha subunit causes autophosphorylation of the beta subunit, triggering a signaling cascade (PI3K/AKT pathway) to regulate glucose uptake [3]. **Why the Other Options are Incorrect:** Options A, B, and D are all **lipid-soluble (lipophilic)** molecules. They easily cross the cell membrane to bind to **Intracellular Receptors**, which act as ligand-activated transcription factors to alter gene expression [1]: * **Steroids (Glucocorticoids, Sex hormones):** Bind to cytoplasmic receptors (Type I), which then translocate to the nucleus [1]. * **Thyroid Hormones (T3, T4):** Bind directly to receptors already located on the chromatin in the nucleus (Type II). * **Vitamin D:** Acts similarly to steroid hormones, binding to nuclear receptors to regulate calcium-binding protein synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Intracellular Receptors:** **"VETTT"** – **V**itamin A/D, **E**strogen (and other steroids), **T**hyroid hormones, **T**estosterone, **T**retinoin. * **Fastest acting receptors:** Ionotropic (Ligand-gated ion channels, e.g., Nicotinic ACh receptor). * **Slowest acting receptors:** Nuclear/Intracellular receptors (due to the time required for gene transcription and protein synthesis). * **Insulin & Growth Factors:** Always remember they use **Tyrosine Kinase** pathways.

Question 446: In which quadrant of the buttock are intramuscular injections typically administered?

A. Inferomedial
B. Superomedial
C. Superolateral (Correct Answer)
D. Superomedial

Explanation: ### Explanation **Correct Answer: C. Superolateral** **Underlying Medical Concept:** The gluteal region is divided into four quadrants by a vertical line through the highest point of the iliac crest and a horizontal line midway between the iliac crest and the ischial tuberosity. The **superolateral (upper-outer) quadrant** is the preferred site for intramuscular (IM) injections because it is the safest area to avoid damaging major neurovascular structures. This quadrant contains a thick mass of the gluteus medius and minimus muscles, providing an excellent site for drug absorption while remaining distant from the sciatic nerve. **Analysis of Incorrect Options:** * **Inferomedial & Inferolateral:** These quadrants are avoided because they lie in close proximity to the **ischial nerve** and the **internal pudendal vessels**. Injections here risk permanent nerve palsy or accidental intravascular administration. * **Superomedial:** This quadrant is contraindicated because the **sciatic nerve** and the **superior gluteal artery/nerve** pass through or near this area. Injury to the sciatic nerve can lead to "foot drop" and sensory loss in the lower limb. **Clinical Pearls for NEET-PG:** * **Sciatic Nerve Protection:** The primary goal of choosing the superolateral quadrant is to avoid the sciatic nerve, which typically emerges below the piriformis muscle in the lower quadrants. * **Ventrogluteal Site:** Modern clinical practice often prefers the ventrogluteal site (gluteus medius) over the dorsogluteal site because it lacks major nerves and thick fat layers, making it the safest overall for IM injections. * **Complications:** "Intramuscular injection-induced sciatic nerve injury" is a classic forensic and clinical case study; the nerve is most vulnerable in the medial and inferior quadrants. * **Alternative:** For infants, the **vastus lateralis** (anterolateral thigh) is the preferred site because the gluteal muscles are underdeveloped until the child begins walking.

Question 447: What is true about inverse agonism?

A. Its action on the target receptors is similar to that of an agonist.
B. It binds to the same receptor binding site as an agonist but exerts the opposite pharmacological effect. (Correct Answer)
C. It is effective against receptors having intrinsic activity without acting of a ligand upon them.
D. None of the above.

Explanation: ### Explanation **1. Why Option B is Correct:** Inverse agonists follow the **Two-State Receptor Model**, which posits that receptors exist in an equilibrium between an inactive ($R$) and an active ($R^*$) state. While a traditional agonist stabilizes the $R^*$ state to increase biological response, an **inverse agonist** binds to the same receptor site but stabilizes the inactive $R$ state. This results in a pharmacological effect that is qualitatively opposite to that of the agonist. **2. Analysis of Incorrect Options:** * **Option A:** This describes a **Full Agonist**. Agonists mimic the endogenous ligand's action, whereas inverse agonists oppose it. * **Option C:** This statement is actually **technically true** in principle (inverse agonists require receptors to have constitutive/intrinsic activity to be observed), but Option B is the **standard pharmacological definition** regarding the binding site and the nature of the effect. In competitive exams like NEET-PG, the definition focusing on "opposite pharmacological effect at the same site" is the preferred answer. * **Option D:** Incorrect, as Option B accurately defines the term. **3. NEET-PG High-Yield Pearls:** * **Constitutive Activity:** This refers to receptors that trigger a biological response even in the absence of a ligand. Inverse agonists are only relevant for receptors with high constitutive activity. * **Antagonist vs. Inverse Agonist:** A **Competitive Antagonist** has zero intrinsic activity (it just blocks the site and prevents the agonist from binding), while an **Inverse Agonist** has negative intrinsic activity (it actively reduces the baseline response). * **Classic Examples:** * **Beta-carbolines** act as inverse agonists at GABA-A receptors (causing anxiety/convulsions, opposite to Benzodiazepines). * **Famotidine** (H2 receptors) and **Losartan** (AT1 receptors) exhibit inverse agonism.

Question 448: Which of the following drugs is an enzyme inducer?

A. Rifampicin (Correct Answer)
B. Isoniazid
C. Ketoconazole
D. Erythromycin

Explanation: **Explanation** The correct answer is **Rifampicin**. **1. Why Rifampicin is correct:** Rifampicin is a potent inducer of the **Cytochrome P450 (CYP450)** enzyme system, specifically the CYP3A4 isoenzyme. [3] Enzyme inducers work by increasing the synthesis of microsomal enzymes in the liver. This leads to an accelerated metabolism of co-administered drugs (e.g., oral contraceptives, warfarin, theophylline), resulting in decreased plasma concentrations and potential therapeutic failure. [1] **2. Why the other options are incorrect:** * **Isoniazid (INH):** Unlike Rifampicin, Isoniazid is a known enzyme **inhibitor**. It inhibits the metabolism of drugs like phenytoin and carbamazepine, leading to their toxicity. * **Ketoconazole:** This is a classic, potent enzyme **inhibitor** (specifically CYP3A4). [1, 2] It is often used in pharmacology questions to demonstrate drug-drug interactions that lead to increased levels of drugs like statins or benzodiazepines. * **Erythromycin:** This macrolide antibiotic is a well-known enzyme **inhibitor**. [2] It can lead to dangerous elevations of drugs like theophylline or cisapride. (Note: Azithromycin is the only macrolide that does not significantly inhibit CYP enzymes). **3. NEET-PG High-Yield Pearls:** To remember these for the exam, use these popular mnemonics: * **Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Enzyme Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**imetidine (Cimetidine), **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**etwork (Azoles/Ketoconazole), **K**rapefruit juice (Grapefruit). **Clinical Tip:** Rifampicin-induced enzyme induction can lead to **contraceptive failure** in women on OCPs; patients should be advised to use alternative barrier methods.

Question 449: A three-year-old child is brought to the emergency department having just ingested a large overdose of an antihistaminic drug. This drug is a weak base capable of entering most tissues, including the brain. On physical examination, the heart rate is 100/minute, blood pressure is 110/60 mm Hg, and the respiratory rate is 20/minute. In this case of poisoning, which of the following is true regarding the management?

A. Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent. (Correct Answer)
B. Urinary excretion would be accelerated by administration of NaHCO3, an alkalinizing agent.
C. More of the drug would be ionized at blood pH than at stomach pH.
D. Absorption of the drug would be faster from the stomach than from the small intestine.

Explanation: ### Explanation **1. Why Option A is Correct: The Concept of Ion Trapping** The drug in question is a **weak base**. According to the Henderson-Hasselbalch principle, a weak base becomes **ionized (charged)** in an acidic environment. Ionized molecules are water-soluble and cannot easily cross lipid membranes (like the renal tubular epithelium) to be reabsorbed into the bloodstream. By administering **Ammonium Chloride (NH₄Cl)**, the urine is acidified. This "traps" the basic drug in its ionized form within the renal tubules, preventing reabsorption and accelerating its excretion. This process is known as **Ion Trapping**. **2. Why the Other Options are Incorrect:** * **Option B:** Alkalinizing the urine with Sodium Bicarbonate (NaHCO₃) would keep a weak base in its **non-ionized** (lipid-soluble) form, promoting its reabsorption back into the blood and worsening the toxicity. (NaHCO₃ is used for weak acid poisoning, like Aspirin). * **Option C:** The stomach has a very low pH (acidic), while blood has a pH of 7.4 (slightly basic). A weak base will be **more ionized in the acidic stomach** and less ionized in the relatively basic blood. * **Option D:** Although the drug is ionized in the stomach, the **small intestine** remains the primary site of absorption for most drugs due to its massive surface area and high vascularity, regardless of the ionization state. **3. NEET-PG High-Yield Clinical Pearls:** * **Acidic Drugs (e.g., Salicylates, Phenobarbital):** Excretion is enhanced by **Urinary Alkalinization** (IV Sodium Bicarbonate). * **Basic Drugs (e.g., Amphetamines, Antihistamines, Morphine):** Excretion is theoretically enhanced by **Urinary Acidification** (Ammonium Chloride/Vitamin C), though clinically, this is rarely done today due to the risk of metabolic acidosis. * **Mnemonic:** "Like dissolves in Like" (Non-ionized/Absorbed); "Opposites Ionize" (Ionized/Excreted). Acidic drug + Basic urine = Excretion.

Question 450: Epinephrine added to a solution of lignocaine for a peripheral nerve block will:

A. Increase risk of convulsions
B. Increase the duration of action of the local anesthetic (Correct Answer)
C. Both increase risk of convulsions and increase the duration of action of the local anesthetic
D. None of these

Explanation: ### Explanation **1. Why Option B is Correct:** Lignocaine is a local anesthetic (LA) that causes vasodilation at the site of injection. When **Epinephrine (Adrenaline)** is added, it acts on **$\alpha_1$-adrenergic receptors** to cause potent **vasoconstriction**. This results in: * **Decreased systemic absorption:** The LA remains at the nerve site for a longer period. * **Increased duration of action:** Since the drug is not washed away by the bloodstream quickly, the block lasts longer. * **Reduced systemic toxicity:** Slower absorption leads to lower peak plasma levels of the LA. * **Decreased bleeding:** Vasoconstriction provides a bloodless field for minor procedures. **2. Why Other Options are Incorrect:** * **Option A:** Epinephrine actually **decreases** the risk of convulsions. Convulsions are a sign of systemic CNS toxicity (due to high plasma levels of LA). By slowing systemic absorption, epinephrine keeps plasma levels low, thereby reducing the risk of CNS and cardiac toxicity. * **Option C:** Incorrect because the risk of convulsions is decreased, not increased. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Standard Concentration:** Epinephrine is typically added to LAs in a concentration of **1:200,000**. * **Contraindications:** Never use LA with Epinephrine for blocks in **"end-artery" areas** (fingers, toes, nose, ear lobules, and penis) as it can cause ischemia and **gangrene**. * **Hypertension/Cardiac Disease:** Use with caution in patients with uncontrolled hypertension or ischemic heart disease due to potential systemic effects of adrenaline. * **Felypressin:** An alternative vasoconstrictor (vasopressin analogue) sometimes used in dental anesthesia when epinephrine is contraindicated.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free